Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-5.7x
Contraction
Streak
4 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -75.28% |
| 2024 | -32.61% |
| 2023 | -17.52% |
| 2022 | -3.36% |
| 2021 | 15.27% |
| 2020 | 13.21% |
| 2019 | 29.05% |
| 2018 | 106.21% |
| 2017 | 43.69% |
| 2016 | 35.79% |